Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;25 Suppl 4(Suppl 4):e25985.
doi: 10.1002/jia2.25985.

Non-communicable diseases by age strata in people living with and without HIV in four African countries

David Chang  1 , Allahna L Esber  1   2 , Nicole F Dear  1   2 , Michael Iroezindu  1   3 , Emmanuel Bahemana  1   4 , Hannah Kibuuka  5 , John Owuoth  6   7 , Jonah Maswai  1   8 , Trevor A Crowell  1   2 , Christina S Polyak  1   2 , Joseph S Cavanaugh  1 , Julie A Ake  1 , Catherine Godfrey  9 ; AFRICOS Study Group  1
Affiliations

Non-communicable diseases by age strata in people living with and without HIV in four African countries

David Chang et al. J Int AIDS Soc. 2022 Sep.

Abstract

Introduction: Non-communicable diseases (NCDs) are an important driver of morbidity among ageing people living with HIV (PLWH). We examined the composite role of age and HIV status on NCDs in people living with and without HIV.

Methods: The African Cohort Study (AFRICOS) prospectively enrols participants aged ≥15 years with and without HIV at 12 sites in Kenya, Tanzania, Uganda and Nigeria. From 21 January 2013 to 1 September 2021, we assessed participants for renal insufficiency (estimated glomerular filtration rate <60 ml/minute/1.73 m2 ), elevated blood pressure (BP) (any systolic BP >139 mmHg or diastolic BP >89 mmHg), obesity (body mass index >30 kg/m2 ), diabetes mellitus (DM) (fasting glucose ≥126 mg/dl or antidiabetic medication) and dysglycemia (fasting glucose ≥99 mg/dl or non-fasting ≥199 mg/dl). Multivariable logistic regression with generalized estimating equations was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for factors associated with each NCD. The main exposure of interest was a composite of HIV status and age dichotomized around 50 years. All models were adjusted for study site and sex. The renal insufficiency model was additionally adjusted for elevated BP and dysglycemia.

Results and discussion: Of 3761 participants with age data, 557 (14.8%) were age ≥50, 2188 (58.2%) were females and 3099 (82.4%) were PLWH. At enrolment, the prevalence of elevated BP, dysglycemia, renal insufficiency and obesity were n = 128 (26.9%), n = 75 (15.8%), n = 8 (1.7%) and n = 40 (8.4%), respectively, for PLWH ≥50. Compared to people without HIV age <50, PLWH age ≥50 had increased adjusted odds of having DM (OR: 2.78, 95% CI: 1.49-5.16), dysglycemia (OR: 1.98, 95% CI: 1.51-2.61) and renal insufficiency (OR: 6.20, 95% CI: 2.31-16.66). There were significant differences by study site, specifically, participants from Nigeria had the highest odds of elevated BP, dysglycemia and renal insufficiency as compared to Uganda.

Conclusions: There was a high burden of NCDs in this African cohort with differences by geographic region. In order to promote healthy ageing with HIV, screening and treatment for common NCDs should be incorporated into routine HIV care with attention paid to geographic heterogeneity to better allocate resources.

Keywords: Africa; HIV care continuum; HIV epidemiology; LMIC; cohort studies; quality of life.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests to disclose.

Figures

Figure 1
Figure 1
Prevalence of non‐communicable diseases at enrolment. The prevalence of NCDs by age and HIV status at enrolment visit. Abbreviations: PLWH, people living with HIV; PLWoH, people living without HIV; BP, blood pressure.
See this image and copyright information in PMC

References

    1. Nakagawa F, Lodwick RK, Smith CJ, Smith R, Cambiano V, Lundgren JD, et al. Projected life expectancy of people with HIV according to timing of diagnosis. AIDS. 2012;26(3):335–43. - PubMed
    1. Patterson S, Cescon A, Samji H, Chan K, Zhang W, Raboud J, et al. Life expectancy of HIV‐positive individuals on combination antiretroviral therapy in Canada. BMC Infect Dis. 2015;15:274. - PMC - PubMed
    1. Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, et al. Life expectancy of persons receiving combination antiretroviral therapy in low‐income countries: a cohort analysis from Uganda. Ann Intern Med. 2011;155(4):209–16. - PubMed
    1. Wandeler G, Johnson LF, Egger M. Trends in life expectancy of HIV‐positive adults on antiretroviral therapy across the globe: comparisons with general population. Curr Opin HIV AIDS. 2016;11(5):492–500. - PMC - PubMed
    1. Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, et al. Closing the gap: increases in life expectancy among treated HIV‐positive individuals in the United States and Canada. PLoS One. 2013;8(12):e81355. - PMC - PubMed

Publication types